http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010000474-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f6467ec9aed68cbacfadafa3a2b7e79
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2523-125
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32f7263a440af1e849c1bb58541e84d3
publicationDate 2010-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010000474-A1
titleOfInvention Dna methylation analysis of regulatory t cells through dna-methylation analysis of the tsdr region of the gene foxp3
abstract The present invention relates to a method, in particular an in vitro method for identifying FoxP3 -positive CD25+CD4+ regulatory T cells of a mammal, comprising analyzing the methylation status of at least one CpG position in the FOXP3 gene, in particular its "upstream" regulatory regions, and in particular the promoter and the TSDR region of the gene foxp3, wherein a demethylation to at least 90% of at least one CpG in the sample as analyzed is indicative for a FoxP3 -positive CD25 + CD4 + regulatory T cell, and the use of said DNA- methylation analysis of the gene of the transcription factor FoxP3 for a detection and quality assurance and control of regulatory T cells. Furthermore, the present invention relates to a kit for performing the above methods as well as respective uses. The present invention furthermore provides an improved method for analyzing the methylation status of at least one CpG position in the gene foxp3 that allows for a precise analysis even from sub-optimal quality samples, such as non-freshly obtained blood or serum samples.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103173552-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020007951-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013523886-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013518574-A
priorityDate 2008-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1826279-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1826278-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128532039
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129356432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226440877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136128704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136053577

Total number of triples: 32.